ChartMill assigns a Buy % Consensus number of 83% to BBLG. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-04-13 | EF Hutton | Reiterate | Buy |
| 2023-04-03 | EF Hutton | Reiterate | Buy |
| 2022-10-18 | EF Hutton | Initiate | Buy |
7 analysts have analysed BBLG and the average price target is 22.7 USD. This implies a price increase of 983.29% is expected in the next year compared to the current price of 2.095.
The consensus rating for BONE BIOLOGICS CORP (BBLG) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering BONE BIOLOGICS CORP (BBLG) is 7.